Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vera N. Senchenko"'
Autor:
Vitaly I Loginov, Alexey A Dmitriev, Vera N Senchenko, Irina V Pronina, Dmitry S Khodyrev, Anna V Kudryavtseva, George S Krasnov, Ganna V Gerashchenko, Larisa I Chashchina, Tatiana P Kazubskaya, Tatiana T Kondratieva, Michael I Lerman, Debora Angeloni, Eleonora A Braga, Vladimir I Kashuba
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0123369 (2015)
The SEMA3B gene is located in the 3p21.3 LUCA region, which is frequently affected in different types of cancer. The objective of our study was to expand our knowledge of the SEMA3B gene as a tumor suppressor and the mechanisms of its inactivation. I
Externí odkaz:
https://doaj.org/article/a619b4bbe46540769d31a45e40d81ecd
Autor:
Vera N Senchenko, George S Krasnov, Alexey A Dmitriev, Anna V Kudryavtseva, Ekaterina A Anedchenko, Eleonora A Braga, Irina V Pronina, Tatiana T Kondratieva, Sergey V Ivanov, Eugene R Zabarovsky, Michael I Lerman
Publikováno v:
PLoS ONE, Vol 6, Iss 3, p e15612 (2011)
CHL1 gene (also known as CALL) on 3p26.3 encodes a one-pass trans-membrane cell adhesion molecule (CAM). Previously CAMs of this type, including L1, were shown to be involved in cancer growth and metastasis.We used Clontech Cancer Profiling Arrays (1
Externí odkaz:
https://doaj.org/article/f4aa5bf366ac4b26b848459e1e00abf8
Autor:
Fuli Wang, Elvira V Grigorieva, Jingfeng Li, Vera N Senchenko, Tatiana V Pavlova, Ekaterina A Anedchenko, Anna V Kudryavtseva, Alexander Tsimanis, Debora Angeloni, Michael I Lerman, Vladimir I Kashuba, George Klein, Eugene R Zabarovsky
Publikováno v:
PLoS ONE, Vol 3, Iss 8, p e3031 (2008)
We identified two 3p21.3 regions (LUCA and AP20) as most frequently affected in lung, breast and other carcinomas and reported their fine physical and gene maps. It is becoming increasingly clear that each of these two regions contains several TSGs.
Externí odkaz:
https://doaj.org/article/9a40705768f24255878be751b7dee944
Autor:
Nanae Harashima, W. Marston Linehan, Richard W. Childs, Vera N. Senchenko, Elizabeth B Malinzak, Anna V. Kudryavtseva, Yoshiyuki Takahashi, Sheila Rao, Elena Cherkasova, Michael I. Lerman, Lev L. Kiselev, Ramaprasad Srinivasan
Publikováno v:
ResearcherID
Abstract 467 Renal cell carcinoma (RCC) has recently been identified as a target for a graft-vs-tumor (GVT) effect following allogeneic hematopoietic cell transplantation (HCT). At the NHLBI, 30 of 76 patients (39%) with metastatic RCC were observed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb70588ce95817e3aa3ea4110b56cec
https://doi.org/10.1182/blood.v114.22.467.467
https://doi.org/10.1182/blood.v114.22.467.467